Amyloid-b peptides (Ab) fibrillation is the hallmark of Alzheimer's disease (AD). However, it has been challenging to discover potent agents in order to inhibit Ab fibrillation. Herein, we demonstrated the effect of resorcinarene on inhibiting Ab fibrillation in vitro via experimental and computational methods.
Introduction
Alzheimer's disease (AD), the most common form of dementia, causes progressive memory loss, behavior, and thinking problems.
1,2 It has become a major threat for human beings around the globe. Approximately 24.3 million people suffer from AD in the world nowadays. 2, 3 In accordance with a recent report, 4 the number of the AD patients is expected to increase up to 81.1 million by 2040. Over the past 30 years, the etiology of the disease has been attributed to the accumulation of the extracellular plaques, which are mainly composed of amyloidb peptides (Ab), and intracellular tangles formed by tau proteins.
5,6
Much scientic research [7] [8] [9] [10] [11] [12] has proven that sequentially cleavage of amyloid precursor protein (APP) by BACE1 and b-and g-secretases can produce Ab monomer, and the aggregation of Ab monomer into amyloid brils is strongly associated with AD. 13 In other words, Ab plays a central role in the pathogenesis of AD. Both Ab 42 and Ab 40 are primary isoforms of Ab, where Ab 42 is considered as the most toxic form, 14 and Ab 40 is the most abundant form. 15 The development of therapeutic agents targeting upstream secretases had been unsuccessful. 16 Thus the development of an inhibitor for early stage Ab brillation could be a promising treatment of AD.
17
The major Ab contains 40 or 42 amino acids with residues from 18 to 42 forming two parallel b sheets. 18 Signicant efforts and progress have gone into developing new amyloid brilla-tion inhibitors. Ab brillation inhibitors are mainly designed in two different ways: peptides or peptide mimetics [19] [20] [21] [22] [23] and organic compounds. 10, [24] [25] [26] [27] However, the challenge to design small molecules for Ab brillation is because protein-protein interaction regions, approximately 20 nm 2 , are larger than the protein-small molecule interaction regions which are around 3-10 nm 2 . 28 Most small molecules, therefore, cannot afford adequate steric hindrance to prevent the aggregation. Supramolecular strategy to block the aggregation process exhibits another option for potent AD therapies. Lee et al. have demonstrated such a strategy by using cucurbit [7] uril (CB [7] ).
29
However, the efficiency of the designed inhibitor is low. More inhibitors -the reported lowest effective concentration ratio of the inhibitor to Ab 42 is approximately 100 -to prevent amyloid brillation are needed (Table S1 †) . In addition to less powerful performance on blocking Ab aggregation, the cytotoxicity of Ab 42 brils cannot be delayed or inhibited by most other designed inhibitors (Table S1 †) . It is, thus, in dire need to develop inhibitors with sufficient potency to delay the onset of Ab brillation and cytotoxicity of Ab 42.
The utility of resorcinarene has expanded greatly in the eld of supramolecular chemistry and biochemistry. [30] [31] [32] Not only the semi-rigid structure and the p-electron rich cavity, but also the hydrogen bonding sites of the molecule, provide an excellent platform for the host-guest complexation.
33,34
These compounds can be functionalized in diverse manners for different applications, such as recognition of amino acids as well as delivery tool in pharmacology. [35] [36] [37] Inspired by such vital applications in host-guest chemistry, we turned to the functionalized resorcinarene as a potential strategy towards the inhibition of Ab amyloid brillation for the rst time. Fig. 1 shows the Ab brillation pathway, where the partial denaturation of the peptide monomer initiates the brillation route. The denatured monomers self-assemble into oligomers and in turn form brils via protobril formation. In a set of sequential events, resorcinarene is expected to interact with Ab in a way that increases the steric hindrance for bril aggregation and abolishes the Ab brillation process which may delay the toxic Ab 42 as well. Herein, we studied such a hypothesis by experimental method, including thioavin T (ThT) binding assay, circular dichroism spectroscopy (CD), atomic force microscopy (AFM), and cytotoxicity assay, as well as theoretical approach using docking calculations and MD simulations. These results demonstrate a great potential application of resorcinarene in retarding Ab brillation, and propose a new possibility for further optimization of the inhibitor design. In particular, resorcinarene as a delivery system with recognition and encapsulation properties will emerge as a promising agent for therapies of Alzheimer's disease.
Experimental section

Synthesis of resorcinarene
The resorcinarene was prepared according to our previous published literature procedures.
38
All characterizations, including NMR, mass-spec, and X-ray crystallography, are consistent with previous reported results. Briey, the resorcinarene precursor was added to a solution which contained formaldehyde, sodium sulde, and water, and stirred for 4 h at 90-95 C. The mixture was cooled down to room temperature, and neutralized with hydrochloric acid. Acetonitrile was added to precipitate sulfonated resorcinarene. Finally, the resulting product 1 (Scheme 1) was recrystallized and washed in the same solvent acetonitrile.
Thioavin T (ThT) uorescence assay
The kinetics of Ab 42 and Ab 40 brillation can be characterized by the uorescence increase of bril-specic dye of thioavin T (ThT). To accomplish this, different concentrations of resorcinarene, including the ratio of peptides to the resorcinarene at 1 : 0, 1 : 0.1, 1 : 1, and 1 : 5, were prepared for examination. At rst, Ab 42 and Ab 40 were dissolved in 1,1,1,3,3,3-hexauoroisopropanol to stabilize the a-helix structure of the peptides. Aer evacuating the solvent, the solution was ltered through a 0.2 mm membrane to remove the pre-brils. Different concentrations of resorcinarene were added to 10 mM Ab in 25 mM PBS buffer solution (pH 7.4), respectively. Thereaer, the mixture were incubated at 37 C, and aliquots of incubation solutions at different time points were collected and then diluted two times into ThT solution (25 mM ThT in 25 mM PBS buffer, pH 7.6). ThT uorescence was measured by a uorescence spectrophotometer (LS-55, Perkin Elmer) at 25 C with a slit width of 5 nm for both excitation and emission. ThT emission was monitored at 480 nm with the excitation at 440 nm.
Circular dichroism (CD) spectroscopy
To gain insights into the effects of resorcinarene on the conformational transition of Ab, far-UV CD spectroscopy (JASCO J-810) were utilized to monitor the secondary structure of Ab over time.
39
Similar to the uorescence characterization, aliquots of incubation solutions described above were collected for CD spectra as well. The spectra was recorded between 190 and 260 nm at room temperature by a 2 mm optical path length quartz cell.
Atomic force microscopy (AFM)
AFM images of samples withdrawn at different incubation times can be studied to directly observe and monitor the formation of brils. Tapping mode was used to observe morphologies during the brillation process. The cantilever has a resonance frequency of approximately 170 kHz with typical force constant of 7.5 N m À1 . To scan the AFM images, aliquots of samples withdrawn at different incubation times were diluted with pure water, drop-coated on a freshly cleaved mica surface, and allowed to dry for at least 1 h.
Cytotoxicity assay
Toxicity tests were performed in a new 24-well cell culture plate. In each well, health fertilized eggs were incubated in 2 ml control sea water or 2 ml dilution of 1 in sea water. For the 1 cytotoxicity test, the plate with fertilized eggs (Strongylocentrotus purpuratus sea urchins) was incubated at 15 C for 48 hours until they reach prism stage embryos. Ab 42 brils and different Ab 42-1 complex were collected from incubated solutions. The plate with fertilized egg (Lytechinus variegatus sea urchins) to test the inhibiting effect of 1 on Ab 42 toxic species were performed at room temperature for 24 hours until they reach prism stage embryos. 100 of embryos were examined and rate of embryo with normal development was calculated. Each experiment was repeated with similar results. The error bars indicate the standard error of the mean.
Ligand docking and molecular dynamics simulations
Possible binding modes of the resorcinarene to Ab 42 amyloid brils were simulated using Potential Energy Landscape Explorer web-server (PELE: http://pele.bsc.es/pele.wt). 40 We hypothesized that the resorcinarene can bind to the ends of the lament and delay the amyloid ber growth by interfering the monomer addition. Accordingly, two most populated conformations from the PELE simulations with the ligand bound on the top or the bottom of the lament were selected for the initial congurations of the subsequent molecular dynamics simulations. Molecular dynamics (MD) simulations of the ligand bound amyloid brils were carried out using Amber14 so-ware. 41 The molecular mechanics parameters of the resorcinarene was prepared using the Generalized Amber Force Fields (GAFF). 42 Atomic partial charges of the ligand were computed using the AM1-BCC charge model embedded in the antechamber program (Table S2 † ). The amyloid lament was modelled using the AmberFF14SB force elds. 43 The MD simulations were initiated from the two most populated structures found from the PELE simulations. Each initial structure was solvated in an octahedral box lled with TIP3P water molecules, where the solute molecule has 11Å margin from the solvation boundary. Counter ions were added to guarantee the charge neutrality. Each solvated system was equilibrated at 300 K for 6 ns, while keeping positions of all carbon atoms at initial values. 100 ns production runs were followed, while restraining alpha carbons of the lament at initial positions using weak harmonic potentials (spring constant was 0.1 kcal mol À1ÅÀ2 ).
Results and discussion
Inhibitory effect of resorcinarene on Ab brillation
The cationic benzothiazole dye, thioavin T (ThT), is well known for its specic staining of amyloid brils, which enhances emission uorescence. Fig. 2a shows the aggregation kinetics of Ab bril formation at different concentrations of 1 by the time dependent ThT uorescence assay. When incubating 10 mM Ab 42 alone, the ThT uorescent prole presented a lag phase within 3 h, a slow elongation, and a saturated phase aer 3 days, while Ab 40 displayed a similar but faster brillation process with an almost negligible lag phase which maintained less than 1 h, an elongation phase within 3 h, and a saturated phase aer 4 h. To evaluate the inhibition activity of 1 against Ab brillation, Ab were present with different concentrations of 1 at the ratio of the resorcinarene to peptides of 0.1, 1, and 5, respectively. At a Ab 42/1 ratio of 0.1, suppression of Ab 42 aggregation was observed. The elongation phase did not start until incubating for 12 h. In contrast to this, it took Ab 42 3 h to enter the same phase in the absence of 1. Adding more 1, the uorescent intensity decreased by over 50% at the plateau. At Ab 42/1 ratio of 5, almost no brils were observed as evidenced by the nearly at curve comparing to others. Overall, ThT proles demonstrated that 1 inhibited Ab 42 brillation in a dose dependent manner. 1 displayed a similar but more effectively inhibition on Ab 40. 1 began to exhibit inhibition effect at Ab 40/ 1 ratio of 0.1. When the Ab 40/1 ratio increased up to 1, the lag phase period extended to approximately 4 h. If the concentration of 1 was further increased, 1 showed a stronger effect of brillation inhibition, which retained active for 5 days. As control experiments, resorcinarene was incubated alone at 37 C for 24 h, and the uorescence spectra of not only resorcinarene ( Fig. S1 †) , also resorcinarene with 20 mM ThT (Fig. S2 †) showed no disturb towards ThT assay tests above. To note, it is surprising to observe that Ab 40 aggregated faster than Ab 42. It may attribute to the protein purity since impure protein tends to aggregate more slowly. However, in accordance with Table S1 † and results above, 1 exhibited excellent potential for effectively inhibiting both Ab 42 and Ab 40 brillation. The other reason leading to the faster Ab 40 aggregation might be that the prepared amyloid-b peptides may contain seeds which can accelerate the brillation process. [44] [45] [46] To further conrm our hypothesis, we carried out additional series of measurements with regard to the aggregation of kinetics of Ab 42 and 40. Preformed brils (seeds) 47 were added to Ab 42 and Ab 40 at the beginning of incubation, respectively. By recording ThT assay of aggregation kinetics, the lag phase time of both amyloidb peptides with additional seeds was found to decrease comparing to that without added seeds. In other words, both Ab 42 and Ab 40 with additional seeds aggregate faster than those without seeds.
The Ab peptides are mainly random coil or a-helical in the native conformation. They undergo a conversion to b-strand during the bril formation, which is consistent with ThT assay examination. To attain a clear perception of the effect of 1 on the conformational conversion of Ab 42 and 40 upon aggregation, far-UV CD spectroscopy was employed to monitor the secondary structure of the Ab peptides over time (Fig. 2b) . Aliquots of Ab 42 and 40 in the absence and presence of inhibitor were collected for CD spectra at different time, respectively. Even though peptides were incubated in PBS buffer which has an inuence on the CD spectra, the spectra obtained is still distinguishable. As shown in Fig. 2b , Ab 42 alone at incubation time 0 had a negative band at around 197 nm, indicating that the initial secondary structure of Ab 42 adopted a random coil form. Aer incubating 12 hours, this peak diminished and shied slightly to approximately 200 nm, suggesting the conformational change of Ab 42. Upon peptides aggregation for 48 hours, a negative valley appeared at 213 nm, which is assigned to b sheet of mature peptide bril. When present with 10 mM 1, Ab 42 showed a similar structure transition with adopting mainly random coil conformations as evidenced from Fig. 2b . However, Ab 42 did not completely convert to b sheet conformation even aer incubating 96 hours comparing to the study of Ab 42 in the absence of 1. That is, 1 can potentially delay the conformational transition of Ab 42. In the case of Ab 40, Fig. S5 † showed a mixture of random coil, b sheet, and b turn forms. Upon peptide aggregation, bands shrink demonstrating conformational change severely where a signicant decrease in the negative absorption around 200 nm. The nal content of b strand conformers at 4 h was much more than that of initial Ab 40. In the presence of 1, it displayed a similar random coil dominated conformations, but undergoing no transition with 24 h incubation, suggesting a delay of brillation process (Fig. S6 †) . It can be concluded that the inhibitory effect of 1 on conformational transition of Ab aggregation from random coils to b strand.
To directly observe and monitor the formation of these Ab 40 and 42 brils, AFM images were obtained in the absence and presence of 1. The inhibition effect of 1 on Ab peptides bril-lation is consistent with the previous observations. As illustrated in Fig. 2c , Ab 42 brils were apparent aer 72 h incubation in the absence of 1, whereas when present with 1, especially with higher concentration, no long brils showed up during the incubation. Ab 40 went through a similar brillation process with a higher rate. Fibrils can be observed clearly only aer 24 h incubation (Fig. S7 †) , in contrast to the fact that no long brils but a few protobrils were recognized when incubating with the inhibitor. To further conrm the contents of the ThT endpoint samples, a pellet assay with an SDS-PAGE gel was prepared.
47 Fig. S4 † showed that brils from the solution without 1 are much larger than that with 1, which again reveals that 1 can retard the aggregation of both amyloid-b peptides.
To note, all the tested Ab and resorcinarene mixtures contained the same amount of Ab, and any increase in the uo-rescent intensity from ThT assay prole may indicate more brils were formed. It is interesting to observe that the nal ThT intensity of resorcinarene mixed Ab solution decreased and stabilized much lower than that of Ab alone, meaning less brils were produced. The amyloid bril formation is a multistage process that depends on the formation of small oligomeric species.
9,48,49 With regard to the inhibition effect, we speculate that resorcinarene interact with Ab lament at early stage. The bound resorcinarene impede inter oligomers association by steric hindrance and delay the onset of bril growth. The hypothesis is in accordance with CD and AFM study where Ab brils were apparent in the absence of resorcinarene while a few oligomers were formed in the presence of the inhibitor.
Cytotoxicity test of resorcinarene to sea urchin embryos
The effective inhibition of Ab bril formation by 1 suggests the potential capability of 1 for therapy of AD application. A series of cell viability tests were conducted to evaluate the cytotoxicity of 1 in the cellulous environment in which sea urchin embryos were selected as a model system due to its extremely sensitive to hazardous materials. Also sea urchin embryos have been widely used for static acute toxicity of many chemicals test. Strongylocentrotus purpuratus sea urchins (Marinus Scientic, Long Beach, CA) were utilized in this study to test the toxicity of 1, and adult animals with ripe gonads were used to collect gametes. Fresh eggs were washed for 3 times with cold ltered articial sea water and mixed with sperm to examine fertilization rate. Only eggs with a fertilization rate greater than 95% were used for the toxicity tests. Three biological replicates using three individual male-female pairings were performed. Fig. 3a showed 90% of embryos retain a normal morphology aer 20 h of incubation with the presence of 20 mg ml À1 1, in which concentration already exhibited signicant effect on inhibition of Ab brillation, indicating low cytotoxicity of 1 to cells. Unfortunately, since sea urchins are extremely sensitive to invading materials, when the concentration of 1 increasing up to 1000 mM, most of the cells failed to survive under the incubation environment. The effective inhibition of Ab 42 cytotoxicity by 1 can suggest potential utility for therapeutic applications. A series of cell viability tests were performed to measure such effects induced by 1. Pure Ab 42 bril reduced the viability of sea urchins cells (Lytechinus variegatus) in normal forms to 0%, whereas the Ab 42-1 complex delayed the formation of Ab 42 toxic species, where the rate of normal embryos increased to 81% with 50 mM 1 (Fig. 3b) . In addition to the normal form of sea urchin cells, there exist some cells alive but unable to swim. In Fig. S8 , † 92% of embryos are alive but in abnormal forms when present with 10 mM pure Ab 42 brils. Applying more 1, the rate decreased, which indicated the reducing toxicity of Ab 42 brils induced by 1.
Resorcinarene binds to the top and the bottom of the Ab 42 lament
The detailed interactions between the resorcinarene and the amyloid lament were studied using molecular docking and molecular dynamics (MD) simulations. The MD simulations were initiated with bound resorcinarene on the top or the bottom of the amyloid bril (Fig. S6 †) . The bound conformations were identied from the results of the docking simulations using the PELE soware. Fig. 4 shows two of the binding modes of the resorcinarene resulting from the 100 ns MD simulations. Aer 80 ns of MD simulations, the root-meansquared deviation (RMSD) of all heavy atoms of the bound resorcinarene converged to <3.0Å from the last conguration at 100 ns. Of note, the RMSD to the initial docked conformation increased to >4.0Å as MD simulation progressed, that suggests a conformational relaxation took place during the course of MD simulations. The solvent accessible surface area of the ligand- amyloid ber complex was always smaller than that of the isolated ligand and amyloid ber. The nding indicates the ligand is always in contact with the amyloid bril. The averaged buried solvent accessible surface area (DSASA) over the last 20 ns was À767Å 2 for the mode 1 and À845Å 2 for the mode 2. We also computed surface area dependent non-polar hydrophobic energies using the formula proposed by Honig's group: E hphobic ¼ g Â DSASA, where g is 0.05 kcal mol
À1ÅÀ2
. 50 The computed non-polar hydrophobic energies averaged over the last 30 ns MD simulations are À38 kcal mol À1 and À42 kcal mol À1 for the mode 1 and the mode 2, respectively. The amount of the nonpolar interaction energies are sufficient to overcome translational-rotational entropic penalty that is +26 kcal mol À1 less favorable for binding. We analyzed favorable interactions across the interface of the bound resorcinarene and the amyloid bril.
In the rst binding mode (Fig. 4a) , thiomethyl groups of the resorcinarene were in contact with methyl group of Ala21 in the amyloid bilayer interface. Also a sp 2 carbon of resorcinol is in contact with the sidechain of Leu34 and Phe19. Likewise, in the second binding mode (Fig. 4b) , thiomethyl groups make nonpolar contacts with Val36 and Leu34. A sp 2 carbon of resorcinol is in contact with the sidechain of Phe19.
Conclusions
In summary, the effective inhibition of Ab brillation by resorcinarene was demonstrated in vitro by the ThT assay, the circular dichroism spectroscopy, and the atomic force microscopy. Using the computational methods, including docking simulations and MD simulations, the binding of resorcinarene was shown to be mediated by non-polar interactions. The advantages that could arise with resorcinarene that is signi-cantly better than others at Ab brillation inhibition include: (1) lower concentration required to block Ab aggregation, (2) low toxicity to seaurchin embryo, which is extremely sensitive to hazardous materials, and (3) the formation of Ab toxic species can be delayed, which all make our designed inhibitor a promising candidate for the treatment of Alzheimer's disease. To our knowledge, it is the rst time for the application of resorcinarene on the Ab brillation. Thus, with the remarkable inhibitory function towards Ab brillation and its capability in encapsulation, resorcinarene presented in this work shows great potential to be applied in pharmaceutical industry or other areas for the treatment of Alzheimer's disease. Fig. 4 Predicted interactions of the resorcinearene and the Ab 42 amyloid filament. Two of the relatively stable interactions patterns are predicted using the PELE and the MD simulations: (a) and (b). The last snapshots from the MD simulations are illustrated. Root-meansquared deviations from the initial docked structure (blue), the last configuration of the MD simulation (red), and the buried surface area of the ligand-protein interface (orange) of each are plotted on bottom.
